Solventum Corporation (SOLV)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Solventum Corporation (SOLV)
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
Key Insights
Critical company metrics and information
Share Price
$69.96Market Cap
$12.09 BillionTotal Outstanding Shares
172.76 Million SharesTotal Employees
22,000Dividend
No dividendIPO Date
March 26, 2024SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.3m.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Operating Activities, Continuing | $169.00 Million |
Net Cash Flow From Operating Activities | $169.00 Million |
Net Cash Flow | $-126.00 Million |
Net Cash Flow From Financing Activities | $-202.00 Million |
Net Cash Flow From Investing Activities | $-93.00 Million |
Net Cash Flow, Continuing | $-126.00 Million |
Net Cash Flow From Investing Activities, Continuing | $-93.00 Million |
Net Cash Flow From Financing Activities, Continuing | $-202.00 Million |
Income Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Operating Income/Loss | $275.00 Million |
Basic Earnings Per Share | $0.70 |
Income/Loss From Continuing Operations Before Tax | $167.00 Million |
Cost Of Revenue | $917.00 Million |
Research and Development | $189.00 Million |
Income Tax Expense/Benefit | $45.00 Million |
Benefits Costs and Expenses | $1.92 Billion |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Net Income/Loss Attributable To Parent | $122.00 Million |
Income/Loss From Continuing Operations After Tax | $122.00 Million |
Basic Average Shares | $173.40 Million |
Revenues | $2.08 Billion |
Diluted Earnings Per Share | $0.70 |
Net Income/Loss | $122.00 Million |
Operating Expenses | $890.00 Million |
Gross Profit | $1.17 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $122.00 Million |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Selling, General, and Administrative Expenses | $701.00 Million |
Income Tax Expense/Benefit, Deferred | $-37.00 Million |
Costs And Expenses | $1.81 Billion |
Diluted Average Shares | $173.90 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Balance Sheet
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Equity Attributable To Parent | $3.19 Billion |
Noncurrent Liabilities | $8.65 Billion |
Assets | $14.74 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Other Current Liabilities | $2.09 Billion |
Fixed Assets | $1.60 Billion |
Other Current Assets | $2.40 Billion |
Long-term Debt | $8.11 Billion |
Current Assets | $3.35 Billion |
Inventory | $953.00 Million |
Accounts Payable | $560.00 Million |
Wages | $251.00 Million |
Liabilities | $11.55 Billion |
Equity | $3.19 Billion |
Other Non-current Liabilities | $540.00 Million |
Current Liabilities | $2.90 Billion |
Noncurrent Assets | $11.39 Billion |
Other Non-current Assets | $7.14 Billion |
Intangible Assets | $2.65 Billion |
Liabilities And Equity | $14.74 Billion |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.